Start Date
November 30, 2009
Primary Completion Date
December 31, 2009
Study Completion Date
December 31, 2009
Irbesartan
CRC, Medizinsiche Klinik 4, Nephrology and Hypertension, University of Erlangen-Nürnberg, Erlangen
Collaborators (1)
Bristol-Myers Squibb
INDUSTRY
University of Erlangen-Nürnberg Medical School
OTHER